NATCO Pharma Asia, a wholly-owned subsidiary (WOS) of Natco Pharma (NATCO) incorporated in Singapore, has acquired 49% of the shareholding in PT NATCO Lotus Farma from PT Lotus Farma Indonesia. NATCO already owns 51% of...
Sun Pharma looks to rise in US with $10 billion Organon buy
Sun Pharmaceutical Industries Ltd, India’s largest drugmaker by market cap and revenue, is evaluating the acquisition of US-based Organon, a specialist in women’s health with an expanding presence in the fast-emerging...
AbbVie denies media reports of talks to buy Revolution Medicines
AbbVie on Wednesday denied it was in talks to buy Revolution Medicines after the Wall Street Journal reported the drugmaker was in advanced discussions to acquire the cancer-drug developer. The company “is not in...
Aurobindo arm to acquire additional 20% stake in JV firm
Aurobindo Pharma on Tuesday said that it will pick up an additional 20 per cent stake in its China-based joint venture for USD 5.12 million. Helix Healthcare BV, a wholly-owned subsidiary of the company, has entered...
Sweden’s Sobi to buy US biotech Arthrosi for up to $1.5 billion to boost gout pipeline
Drugmaker Swedish Orphan Biovitrum said on Saturday it had agreed to acquire U.S.-based biotechnology company Arthrosi Therapeutics for up to $1.5 billion to strengthen its portfolio of gout treatments. Sobi will pay...
Mirum to buy Bluejay for up to $820 million in bet on liver-disease drug
Mirum Pharmaceuticals said on Monday it will buy Bluejay Therapeutics in a deal worth up to $820 million, adding a late-stage experimental drug for a severe liver disease. The deal will give the company worldwide rights...
Biocon fully integrates Biocon Biologics in $5.5 billion deal
Indian biopharmaceutical company Biocon said on Saturday it would fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary, consolidating Biocon’s biosimilars and generics businesses under one...
Lupin Pharma, TPG Capital & EQT in talks to acquire Lalvani family-owned Vitabiotics
Indian drugmaker Lupin and a clutch of private equity investors including EQT Partners and TPG Capital are in separate early-stage discussions to acquire UK’s largest nutraceutical company, Vitabiotics, people aware of...
ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals
The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company. Further, the board has...
White Oak, Siguler Guff, Creador buy into La Renon Pharma
An investor consortium comprising White Oak Capital Management, US private equity firm Siguler Guff, and Kuala Lumpur-based Creador has acquired about 10% of the pharmaceutical company La Renon Healthcare, said people...
Advent, Warburg join race for stake in Encube Ethicals
Global private equity firms Advent International and Warburg Pincus have joined the race for a stake purchase in contract drug maker Encube Ethicals Pvt. Ltd, three people aware of the development said. Apart from...
Novo Holdings to sell about 8% stake in UK’s ConvaTec, bookrunner says
Novo Holdings, which controls obesity drugmaker Novo Nordisk, will sell 154.5 million shares, or 7.8% of its stake, in British medical products maker ConvaTec Group, a bookrunner for the offering said on Monday. Novo is...
